Oil & Gas Exploration & Production
Compare Stocks
5 / 10Stock Comparison
EPSN vs XOM vs WMB vs CVX vs KMI
Revenue, margins, valuation, and 5-year total return — side by side.
Oil & Gas Integrated
Oil & Gas Midstream
Oil & Gas Integrated
Oil & Gas Midstream
EPSN vs XOM vs WMB vs CVX vs KMI — Key Financials
Market cap, revenue, margins, and valuation side-by-side.
| Company Snapshot | |||||
|---|---|---|---|---|---|
| Industry | Oil & Gas Exploration & Production | Oil & Gas Integrated | Oil & Gas Midstream | Oil & Gas Integrated | Oil & Gas Midstream |
| Market Cap | $130M | $620.85B | $89.22B | $364.18B | $70.10B |
| Revenue (TTM) | $46M | $323.90B | $11.92B | $184.43B | $17.52B |
| Net Income (TTM) | $6M | $28.84B | $2.84B | $12.30B | $3.31B |
| Gross Margin | 47.6% | 21.7% | 62.8% | 30.4% | 46.9% |
| Operating Margin | 21.9% | 10.5% | 38.8% | 9.0% | 28.6% |
| Forward P/E | 17.3x | 14.8x | 31.2x | 15.0x | 22.3x |
| Total Debt | $477K | $43.54B | $29.36B | $46.74B | $32.39B |
| Cash & Equiv. | $7M | $10.68B | $63M | $6.47B | $109M |
EPSN vs XOM vs WMB vs CVX vs KMI — Long-Term Stock Performance
Price return indexed to 100 at period start. Dividends excluded.
| Stock | May 20 | May 26 | Return |
|---|---|---|---|
| Epsilon Energy Ltd. (EPSN) | 100 | 202.1 | +102.1% |
| Exxon Mobil Corpora… (XOM) | 100 | 322.2 | +222.2% |
| The Williams Compan… (WMB) | 100 | 357.1 | +257.1% |
| Chevron Corporation (CVX) | 100 | 199.0 | +99.0% |
| Kinder Morgan, Inc. (KMI) | 100 | 199.4 | +99.4% |
Price return only. Dividends and distributions are not included.
Quick Verdict: EPSN vs XOM vs WMB vs CVX vs KMI
Each card shows where this stock fits in a portfolio — not just who wins on paper.
EPSN is the clearest fit if your priority is sleep-well-at-night and defensive.
- Lower volatility, beta 0.15, Low D/E 0.5%, current ratio 2.02x
- Beta 0.15, yield 4.3%, current ratio 2.02x
- 4.3% yield, 1-year raise streak, vs XOM's 2.7%
XOM has the current edge in this matchup, primarily because of its strength in momentum and efficiency.
- +43.9% vs EPSN's -4.7%
- 6.4% ROA vs CVX's 4.2%, ROIC 8.6% vs 6.2%
WMB is the #2 pick in this set and the best alternative if growth exposure and long-term compounding is your priority.
- Rev growth 13.8%, EPS growth 17.6%, 3Y rev CAGR 2.9%
- 371.1% 10Y total return vs KMI's 142.1%
- 13.8% revenue growth vs CVX's -4.6%
- 23.8% margin vs CVX's 6.7%
Among these 5 stocks, CVX doesn't own a clear edge in any measured category.
KMI ranks third and is worth considering specifically for income & stability and valuation efficiency.
- Dividend streak 9 yrs, beta 0.10, yield 3.7%
- PEG 0.23 vs WMB's 0.47
- Better valuation composite
- Beta 0.10 vs WMB's 0.17, lower leverage
See the full category breakdown
| Category | Winner | Why |
|---|---|---|
| Growth | 13.8% revenue growth vs CVX's -4.6% | |
| Value | Better valuation composite | |
| Quality / Margins | 23.8% margin vs CVX's 6.7% | |
| Stability / Safety | Beta 0.10 vs WMB's 0.17, lower leverage | |
| Dividends | 4.3% yield, 1-year raise streak, vs XOM's 2.7% | |
| Momentum (1Y) | +43.9% vs EPSN's -4.7% | |
| Efficiency (ROA) | 6.4% ROA vs CVX's 4.2%, ROIC 8.6% vs 6.2% |
EPSN vs XOM vs WMB vs CVX vs KMI — Revenue Breakdown by Segment
How each company's revenue is distributed across its business units
EPSN vs XOM vs WMB vs CVX vs KMI — Financial Metrics
Side-by-side numbers across 5 stocks — who leads on profitability, valuation, growth, and risk.
Who Leads Where
XOM leads in 1 of 6 categories
EPSN leads 1 • WMB leads 1 • CVX leads 0 • KMI leads 0 • 3 tied
Explore the data ↓Income & Cash Flow (Last 12 Months)
Evenly matched — EPSN and WMB each lead in 3 of 6 comparable metrics.
Income & Cash Flow (Last 12 Months)
XOM is the larger business by revenue, generating $323.9B annually — 7086.1x EPSN's $46M. WMB is the more profitable business, keeping 23.8% of every revenue dollar as net income compared to CVX's 6.7%. On growth, EPSN holds the edge at +23.2% YoY revenue growth, suggesting stronger near-term business momentum.
| Metric | |||||
|---|---|---|---|---|---|
| RevenueTrailing 12 months | $46M | $323.9B | $11.9B | $184.4B | $17.5B |
| EBITDAEarnings before interest/tax | $22M | $59.9B | $6.8B | $37.1B | $7.5B |
| Net IncomeAfter-tax profit | $6M | $28.8B | $2.8B | $12.3B | $3.3B |
| Free Cash FlowCash after capex | $10M | $23.6B | $722M | $16.2B | $3.9B |
| Gross MarginGross profit ÷ Revenue | +47.6% | +21.7% | +62.8% | +30.4% | +46.9% |
| Operating MarginEBIT ÷ Revenue | +21.9% | +10.5% | +38.8% | +9.0% | +28.6% |
| Net MarginNet income ÷ Revenue | +12.9% | +8.9% | +23.8% | +6.7% | +18.9% |
| FCF MarginFCF ÷ Revenue | +22.7% | +7.3% | +6.1% | +8.8% | +22.2% |
| Rev. Growth (YoY)Latest quarter vs prior year | +23.2% | -1.3% | -0.6% | -5.3% | +13.5% |
| EPS Growth (YoY)Latest quarter vs prior year | +2.0% | -11.0% | +24.6% | -24.5% | +37.5% |
Valuation Metrics
XOM leads this category, winning 3 of 7 comparable metrics.
Valuation Metrics
At 21.9x trailing earnings, XOM trades at a 67% valuation discount to EPSN's 66.9x P/E. Adjusting for growth (PEG ratio), KMI offers better value at 0.24x vs WMB's 0.52x — a lower PEG means you pay less per unit of expected earnings growth.
| Metric | |||||
|---|---|---|---|---|---|
| Market CapShares × price | $130M | $620.8B | $89.2B | $364.2B | $70.1B |
| Enterprise ValueMkt cap + debt − cash | $124M | $653.7B | $118.5B | $404.5B | $102.4B |
| Trailing P/EPrice ÷ TTM EPS | 66.89x | 21.86x | 34.09x | 27.53x | 23.00x |
| Forward P/EPrice ÷ next-FY EPS est. | 17.29x | 14.79x | 31.23x | 15.02x | 22.29x |
| PEG RatioP/E ÷ EPS growth rate | — | — | 0.52x | — | 0.24x |
| EV / EBITDAEnterprise value multiple | 9.09x | 10.91x | 17.56x | 10.89x | 14.09x |
| Price / SalesMarket cap ÷ Revenue | 4.11x | 1.92x | 7.47x | 1.97x | 4.14x |
| Price / BookPrice ÷ Book value/share | 1.33x | 2.37x | 5.94x | 1.76x | 2.16x |
| Price / FCFMarket cap ÷ FCF | — | 26.29x | 88.77x | 21.95x | 21.76x |
Profitability & Efficiency
EPSN leads this category, winning 4 of 9 comparable metrics.
Profitability & Efficiency
WMB delivers a 19.0% return on equity — every $100 of shareholder capital generates $19 in annual profit, vs $6 for EPSN. EPSN carries lower financial leverage with a 0.00x debt-to-equity ratio, signaling a more conservative balance sheet compared to WMB's 1.96x. On the Piotroski fundamental quality scale (0–9), KMI scores 8/9 vs XOM's 3/9, reflecting strong financial health.
| Metric | |||||
|---|---|---|---|---|---|
| ROE (TTM)Return on equity | +5.9% | +10.7% | +19.0% | +7.2% | +10.3% |
| ROA (TTM)Return on assets | +4.7% | +6.4% | +4.9% | +4.2% | +4.5% |
| ROICReturn on invested capital | +2.9% | +8.6% | +7.7% | +6.2% | +5.6% |
| ROCEReturn on capital employed | +3.0% | +8.9% | +8.7% | +6.6% | +7.0% |
| Piotroski ScoreFundamental quality 0–9 | 6 | 3 | 7 | 5 | 8 |
| Debt / EquityFinancial leverage | 0.00x | 0.16x | 1.96x | 0.24x | 1.00x |
| Net DebtTotal debt minus cash | -$6M | $32.9B | $29.3B | $40.3B | $32.3B |
| Cash & Equiv.Liquid assets | $7M | $10.7B | $63M | $6.5B | $109M |
| Total DebtShort + long-term debt | $476,911 | $43.5B | $29.4B | $46.7B | $32.4B |
| Interest CoverageEBIT ÷ Interest expense | 157.74x | 69.44x | 3.37x | 17.22x | 2.86x |
Total Returns (Dividends Reinvested)
WMB leads this category, winning 4 of 6 comparable metrics.
Total Returns (Dividends Reinvested)
A $10,000 investment in WMB five years ago would be worth $32,449 today (with dividends reinvested), compared to $17,622 for EPSN. Over the past 12 months, XOM leads with a +43.9% total return vs EPSN's -4.7%. The 3-year compound annual growth rate (CAGR) favors WMB at 38.6% vs CVX's 8.2% — a key indicator of consistent wealth creation.
| Metric | |||||
|---|---|---|---|---|---|
| YTD ReturnYear-to-date | +29.2% | +20.3% | +20.7% | +18.2% | +15.9% |
| 1-Year ReturnPast 12 months | -4.7% | +43.9% | +27.2% | +39.5% | +18.3% |
| 3-Year ReturnCumulative with dividends | +27.8% | +44.9% | +166.3% | +26.7% | +107.0% |
| 5-Year ReturnCumulative with dividends | +76.2% | +164.6% | +224.5% | +94.0% | +108.4% |
| 10-Year ReturnCumulative with dividends | -66.9% | +105.0% | +371.1% | +135.8% | +142.1% |
| CAGR (3Y)Annualised 3-year return | +8.5% | +13.2% | +38.6% | +8.2% | +27.4% |
Risk & Volatility
Evenly matched — XOM and WMB each lead in 1 of 2 comparable metrics.
Risk & Volatility
XOM is the less volatile stock with a -0.15 beta — it tends to amplify market swings less than WMB's 0.17 beta. A beta below 1.0 means the stock typically moves less than the S&P 500. WMB currently trades 94.2% from its 52-week high vs EPSN's 69.2% drawdown — a narrower gap to the peak suggests stronger recent price momentum.
| Metric | |||||
|---|---|---|---|---|---|
| Beta (5Y)Sensitivity to S&P 500 | 0.15x | -0.15x | 0.17x | -0.05x | 0.10x |
| 52-Week HighHighest price in past year | $8.50 | $176.41 | $77.41 | $214.71 | $34.73 |
| 52-Week LowLowest price in past year | $4.20 | $101.19 | $55.82 | $133.77 | $25.60 |
| % of 52W HighCurrent price vs 52-week peak | +69.2% | +83.0% | +94.2% | +85.0% | +90.7% |
| RSI (14)Momentum oscillator 0–100 | 44.5 | 42.4 | 52.8 | 42.1 | 42.5 |
| Avg Volume (50D)Average daily shares traded | 246K | 18.9M | 5.8M | 11.0M | 12.4M |
Analyst Outlook
Evenly matched — EPSN and XOM each lead in 1 of 2 comparable metrics.
Analyst Outlook
Analyst consensus: XOM as "Hold", WMB as "Buy", CVX as "Buy", KMI as "Hold". Consensus price targets imply 42.9% upside for EPSN (target: $8) vs 4.6% for CVX (target: $191). For income investors, EPSN offers the higher dividend yield at 4.25% vs XOM's 2.73%.
| Metric | |||||
|---|---|---|---|---|---|
| Analyst RatingConsensus buy/hold/sell | — | Hold | Buy | Buy | Hold |
| Price TargetConsensus 12-month target | $8.40 | $160.43 | $79.00 | $190.93 | $35.00 |
| # AnalystsCovering analysts | — | 55 | 34 | 53 | 34 |
| Dividend YieldAnnual dividend ÷ price | +4.3% | +2.7% | +2.7% | +3.8% | +3.7% |
| Dividend StreakConsecutive years of raises | 1 | 26 | 8 | 8 | 9 |
| Dividend / ShareAnnual DPS | $0.25 | $4.00 | $2.00 | $6.87 | $1.17 |
| Buyback YieldShare repurchases ÷ mkt cap | +1.4% | +3.3% | 0.0% | +3.3% | 0.0% |
XOM leads in 1 of 6 categories (Valuation Metrics). EPSN leads in 1 (Profitability & Efficiency). 3 tied.
EPSN vs XOM vs WMB vs CVX vs KMI: Key Questions Answered
10 questions · data-driven answers · updated daily
01Is EPSN or XOM or WMB or CVX or KMI a better buy right now?
For growth investors, The Williams Companies, Inc.
(WMB) is the stronger pick with 13. 8% revenue growth year-over-year, versus -4. 6% for Chevron Corporation (CVX). Exxon Mobil Corporation (XOM) offers the better valuation at 21. 9x trailing P/E (14. 8x forward), making it the more compelling value choice. Analysts rate The Williams Companies, Inc. (WMB) a "Buy" — based on 34 analyst ratings — the highest consensus in this comparison. The "better buy" depends entirely on your goals: growth investors should weight revenue trajectory, value investors should weight P/E and PEG, and income investors should weight dividend yield and streak.
02Which has the better valuation — EPSN or XOM or WMB or CVX or KMI?
On trailing P/E, Exxon Mobil Corporation (XOM) is the cheapest at 21.
9x versus Epsilon Energy Ltd. at 66. 9x. On forward P/E, Exxon Mobil Corporation is actually cheaper at 14. 8x. The PEG ratio (P/E divided by earnings growth rate) is the most growth-adjusted single valuation metric: Kinder Morgan, Inc. wins at 0. 23x versus The Williams Companies, Inc. 's 0. 47x — a PEG below 1. 0 traditionally signals the market is underpricing earnings growth.
03Which is the better long-term investment — EPSN or XOM or WMB or CVX or KMI?
Over the past 5 years, The Williams Companies, Inc.
(WMB) delivered a total return of +224. 5%, compared to +76. 2% for Epsilon Energy Ltd. (EPSN). Over 10 years, the gap is even starker: WMB returned +371. 1% versus EPSN's -66. 9%. Past returns do not guarantee future results, and the stock with the higher historical return may already have its best growth priced in.
04Which is safer — EPSN or XOM or WMB or CVX or KMI?
By beta (market sensitivity over 5 years), Exxon Mobil Corporation (XOM) is the lower-risk stock at -0.
15β versus The Williams Companies, Inc. 's 0. 17β — meaning WMB is approximately -217% more volatile than XOM relative to the S&P 500. On balance sheet safety, Epsilon Energy Ltd. (EPSN) carries a lower debt/equity ratio of 0% versus 196% for The Williams Companies, Inc. — giving it more financial flexibility in a downturn.
05Which is growing faster — EPSN or XOM or WMB or CVX or KMI?
By revenue growth (latest reported year), The Williams Companies, Inc.
(WMB) is pulling ahead at 13. 8% versus -4. 6% for Chevron Corporation (CVX). On earnings-per-share growth, the picture is similar: The Williams Companies, Inc. grew EPS 17. 6% year-over-year, compared to -71. 6% for Epsilon Energy Ltd.. Over a 3-year CAGR, WMB leads at 2. 9% annualised revenue growth. Higher growth typically commands a higher valuation multiple — check whether the premium P/E or P/S is justified by the growth rate using the PEG ratio.
06Which has better profit margins — EPSN or XOM or WMB or CVX or KMI?
The Williams Companies, Inc.
(WMB) is the more profitable company, earning 21. 9% net margin versus 6. 1% for Epsilon Energy Ltd. — meaning it keeps 21. 9% of every revenue dollar as bottom-line profit. Operating margin tells a similar story: WMB leads at 36. 8% versus 9. 0% for CVX. At the gross margin level — before operating expenses — KMI leads at 43. 7%, reflecting greater pricing power or product mix advantage. Stronger margins indicate durable pricing power, lower cost of revenue, or higher mix of software/services. They are one of the clearest signs of business quality.
07Is EPSN or XOM or WMB or CVX or KMI more undervalued right now?
The PEG ratio (forward P/E divided by expected earnings growth rate) is the most precise measure of undervaluation relative to growth potential.
By this metric, Kinder Morgan, Inc. (KMI) is the more undervalued stock at a PEG of 0. 23x versus The Williams Companies, Inc. 's 0. 47x. A PEG below 1. 0 is traditionally considered the threshold for growth-adjusted undervaluation. On forward earnings alone, Exxon Mobil Corporation (XOM) trades at 14. 8x forward P/E versus 31. 2x for The Williams Companies, Inc. — 16. 4x cheaper on a one-year earnings basis. Analyst consensus price targets imply the most upside for EPSN: 42. 9% to $8. 40.
08Which pays a better dividend — EPSN or XOM or WMB or CVX or KMI?
All stocks in this comparison pay dividends.
Epsilon Energy Ltd. (EPSN) offers the highest yield at 4. 3%, versus 2. 7% for Exxon Mobil Corporation (XOM).
09Is EPSN or XOM or WMB or CVX or KMI better for a retirement portfolio?
For long-horizon retirement investors, Exxon Mobil Corporation (XOM) is the stronger choice — it scores higher on the combination of lower volatility, dividend reliability, and long-term compounding (low volatility (β -0.
15), 2. 7% yield, +105. 0% 10Y return). Both have compounded well over 10 years (XOM: +105. 0%, EPSN: -66. 9%), confirming both are viable long-term holds — but the lower-volatility option typically results in less emotional selling during corrections. Retirement portfolios generally favour predictability over maximum returns. Consult a financial advisor before making allocation decisions.
10What are the main differences between EPSN and XOM and WMB and CVX and KMI?
Both stocks operate in the Energy sector, making this a peer-level intra-sector comparison — the same macro tailwinds and headwinds will affect both.
In terms of investment character: EPSN is a small-cap income-oriented stock; XOM is a large-cap quality compounder stock; WMB is a mid-cap quality compounder stock; CVX is a large-cap income-oriented stock; KMI is a mid-cap income-oriented stock. These fundamental differences mean investors should not choose between them on a single metric — the "better stock" depends entirely on which of these characteristics aligns with your investment strategy.
Find Stocks Like These
Explore pre-built screens for each stock's profile, or build a custom screen to find stocks that outperform all of them.
You Might Also Compare
Based on how these companies actually compete and overlap — not just which sector they're filed under.